Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference92 articles.
1. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine;Xue;Signal Transduct. Target Ther.,2022
2. The advances in epigenetics for cancer radiotherapy;Wang;Int J. Mol. Sci.,2022
3. Current treatment and recent progress in gastric cancer;Joshi;CA Cancer J. Clin.,2021
4. Anticancer activities of TCM and their active components against tumor metastasis;Wang;Biomed. Pharm.,2021
5. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine;Lu;Chin. Med.,2019
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products;Phytomedicine;2024-09
2. Exploring the protective effect and mechanism of icariside II on the bladder in a rat model of radiation cystitis based on transcriptome sequencing;International Journal of Radiation Biology;2024-08-21
3. Cancer-Related Therapeutic Potential of Epimedium and Its Extracts;Nutrition and Cancer;2024-07-26
4. Harnessing the immunomodulatory potential of natural products in precision medicine—a comprehensive review;Exploration of Drug Science;2024-06-27
5. Icariin alleviates oxygen‐induced retinopathy by targeting microglia hexokinase 2;Immunology;2024-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3